Interpace Biosciences, Inc. (IDXG)
1.523
-0.09
(-5.42%)
USD |
OTCM |
Aug 21, 16:00
Interpace Biosciences Price : 1.523 for Aug. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 1.51 | 1.542 | 1.41 | 1.523 | 9829.00 |
| Aug 20, 2026 | 1.58 | 1.630 | 1.58 | 1.61 | 29804.00 |
| Aug 19, 2026 | 1.585 | 1.585 | 1.57 | 1.57 | 350.00 |
| Aug 18, 2026 | 1.64 | 1.64 | 1.59 | 1.60 | 6910.00 |
| Aug 17, 2026 | 1.65 | 1.70 | 1.63 | 1.70 | 9136.00 |
| Aug 14, 2026 | 1.67 | 1.70 | 1.60 | 1.66 | 21706.00 |
| Aug 13, 2026 | 1.67 | 1.685 | 1.63 | 1.67 | 24225.00 |
| Aug 12, 2026 | 1.67 | 1.67 | 1.64 | 1.67 | 2103.00 |
| Aug 11, 2026 | 1.66 | 1.70 | 1.66 | 1.669 | 18248.00 |
| Aug 10, 2026 | 1.64 | 1.70 | 1.64 | 1.70 | 13703.00 |
| Aug 07, 2026 | 1.61 | 1.61 | 1.61 | 1.61 | 501.00 |
| Aug 06, 2026 | 1.58 | 1.642 | 1.54 | 1.64 | 1300.00 |
| Aug 05, 2026 | 1.45 | 1.498 | 1.45 | 1.498 | 1015.00 |
| Aug 04, 2026 | 1.45 | 1.63 | 1.41 | 1.63 | 4107.00 |
| Aug 03, 2026 | 1.44 | 1.59 | 1.44 | 1.59 | 1901.00 |
| Jul 31, 2026 | 1.517 | 1.517 | 1.517 | 1.517 | 100.00 |
| Jul 30, 2026 | 1.434 | 1.44 | 1.434 | 1.44 | 411.00 |
| Jul 29, 2026 | 1.55 | 1.552 | 1.55 | 1.552 | 300.00 |
| Jul 28, 2026 | 1.51 | 1.552 | 1.51 | 1.552 | 1700.00 |
| Jul 27, 2026 | 1.49 | 1.545 | 1.49 | 1.545 | 320.00 |
| Jul 24, 2026 | 1.45 | 1.46 | 1.441 | 1.46 | 4002.00 |
| Jul 23, 2026 | 1.484 | 1.484 | 1.34 | 1.45 | 2536.00 |
| Jul 22, 2026 | 1.46 | 1.51 | 1.46 | 1.51 | 4632.00 |
| Jul 21, 2026 | 1.50 | 1.504 | 1.50 | 1.504 | 1217.00 |
| Jul 20, 2026 | 1.45 | 1.505 | 1.45 | 1.49 | 4423.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Exlites Holdings International, Inc. | 0.35 |
| Xcelerate, Inc. | 0.0102 |
| Vivos Therapeutics, Inc. | 0.2765 |
| Hinge Health, Inc. | 90.05 |
| PD-Rx Pharmaceuticals, Inc. | 3.35 |
Price Related Metrics
| PE Ratio | 1.726 |
| PS Ratio | 1.167 |
| PEG Ratio | 0.0397 |
| Price to Book Value | 1.815 |
| Price to Free Cash Flow | 10.28 |
| Earnings Yield | 57.95% |
| Market Cap | 42.18M |
| PEGY Ratio | 0.0397 |
| Operating PE Ratio | 10.13 |
| Normalized PE Ratio | 1.732 |